{"product_id":"mass-spectrometry-market-by-technology-hybrid-triple-quadrupole-qtof-ftms-single-quadrupole-tof-ion-trap-application-life-science-research-clinical-diagnostics-qa-qc-end-user-pharma-biotech-environmental-f-b-global-forecasts-to-2028","title":"Mass Spectrometry Market by Technology (Hybrid (Triple Quadrupole, QTOF, FTMS), Single (Quadrupole, TOF, Ion Trap)), Application (Life Science Research, Clinical Diagnostics, QA\/QC), End-User (Pharma-Biotech, Environmental, F\u0026B) - Global Forecasts to 2028","description":"\u003cp\u003eMass Spectrometry Market by Technology (Hybrid (Triple Quadrupole, QTOF, FTMS), Single (Quadrupole, TOF, Ion Trap)), Application (Life Science Research, Clinical Diagnostics, QA\/QC), End-User (Pharma-Biotech, Environmental, F\u0026amp;B) - Global Forecasts to 2028\u003c\/p\u003e\n\n\u003cp\u003eThe global mass spectrometry market is projected to reach USD 6.8 billion by 2028 from USD 4.7 billion in 2023, growing at a CAGR of 7.5% during the forecast period. The rise in advantages offered by mass spectrometry to be used in therapeutics is one of the major factors anticipated to boost market growth in the forecasting years.\u003c\/p\u003e \n\n\u003cp\u003e“The instrument segment to hold the largest share of the market in 2023”\u003c\/p\u003e\n\n\u003cp\u003eBased on product, the mass spectrometry market is segmented into instrument and software \u0026amp; services. Instruments are expected to dominate the mass spectrometry market during the forecast period. Due to its excellent high throughput screening, ability of rapid and high-resolution testing, and usage for various applications is highly advantageous.\u003c\/p\u003e\n\n\u003cp\u003e“The LC-MS segment to hold the largest share of the market in 2023”\u003c\/p\u003e\n\n\u003cp\u003eBased on sample preparation technique, the mass spectrometry is segmented into GC-MS, LC-MS, ICP-MS, and others.  LC-MS are expected to dominate the mass spectrometry market during the forecast period. The growth is attributed to its broad applicability to a wide range of rigorous demands of the analytical market and industries.\u003c\/p\u003e\n\n\u003cp\u003e“The OMICS research segment is projected to register the highest CAGR during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eBased on applications, the mass spectrometry market is segmented into OMICS research, drug discovery, environmental testing, food testing, pharma-biopharma manufacturing, clinical diagnostics, applied industries, and other applications. The OMICS research segment is estimated to hold the largest market share of the mass spectrometry market during the forecast period. The segment includes life science related research like Genomics, Proteomics and Metabolomics.\u003c\/p\u003e\n\n\u003cp\u003e“The pharmaceutical companies’ segment is projected to register the highest CAGR during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eThe end-user market is segmented pharmaceutical companies, biotechnology companies, research labs \u0026amp; academic institutes, environmental testing labs, F\u0026amp;B industry, forensic labs, petrochemical industry and other end users. Pharmaceutical companies accounted for the largest share of the global mass spectrometry market in 2022. This end-user segment is also estimated to grow at the highest CAGR during the forecast period. This can be attributed to the factors such as presence of stringent regulatory guidelines for drug development and safety and availability of government and corporate funding for pharmaceutical research.\u003c\/p\u003e\n\n\u003cp\u003e“The market in the North America region is expected to hold significant market share for mass spectrometry in 2022.”\u003c\/p\u003e\n\n\u003cp\u003eThe mass spectrometry market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for mass spectrometry in 2022. The growth of the mass spectrometry market in this region can be attributed to the increasing investments in pharmaceutical R\u0026amp;D and government funding for R\u0026amp;D activities.\u003c\/p\u003e\n\n\u003cp\u003eA breakdown of the primary participants referred to for this report is provided below:\u003c\/p\u003e\n\n\u003cp\u003eBy Company Type: Tier 1–50%, Tier 2–30%, and Tier 3– 20%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation: C-level–37%, Director-level–29%, and Others–34%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America–27%, Asia Pacific–33%,  Europe–30%, ROW-10%\u003c\/p\u003e\n\n\u003cp\u003eThe prominent players in the mass spectrometry market are SCIEX AB (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation (US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), among others.\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage\u003c\/p\u003e\n\n\u003cp\u003eThis report studies the mass spectrometry market based on technology, sample preparation technology, application, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).\u003c\/p\u003e\n\n\u003cp\u003eReasons to Buy the Report\u003c\/p\u003e \n\n\u003cp\u003eThe report will enable established firms as well as entrants\/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.\u003c\/p\u003e\n\n\u003cp\u003eThis report provides insights on the following pointers:\u003c\/p\u003e\n\n\u003cp\u003eAnalysis of key drivers (technological advancements in mass spectrometers, government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R\u0026amp;D, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production), restraints (premium product pricing), opportunities (growth potential offered by emerging markets), and challenges (dearth of skilled professionals) influencing the growth of mass spectrometry market\u003c\/p\u003e\n\n\u003cp\u003eMarket Penetration: Comprehensive information on the product portfolios offered by the top players in the mass spectrometry market\u003c\/p\u003e\n\n\u003cp\u003eProduct Development\/Innovation: Detailed insights on the upcoming trends, R\u0026amp;D activities, and product launches in the mass spectrometry market\u003c\/p\u003e\n\n\u003cp\u003eMarket Development: Comprehensive information on lucrative emerging regions\u003c\/p\u003e\n\n\u003cp\u003eMarket Diversification: Exhaustive information about new products, growing geographies, and recent developments in the mass spectrometry market\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 252 Pages \/ MCW16230847","offer_id":47647173017906,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/mass-spectrometry-market-by-technology-hybrid-triple-quadrupole-qtof-ftms-single-quadrupole-tof-ion-trap-application-life-science-research-clinical-diagnostics-qa-qc-end-user-pharma-biotech-environmental-f-b-global-forecasts-to-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}